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Overexpression of Hedgehog Signaling Is Associated
with Epidermal Tumor Formation in Vitamin D
Receptor–Null Mice
Arnaud E. Teichert1, Hashem Elalieh1, Peter M. Elias2, JoEllen Welsh3 and Daniel D. Bikle1,2
The vitamin D receptor (VDR) ligand, 1,25 dihydroxyvitamin D3 (1,25(OH)2D3), reduces proliferation and enhances
differentiation, and thus has been investigated for a role in preventing or treating cancer. Mice deficient for the
VDR display a hyperproliferative response in the hair follicle and epidermis and decreased epidermal
differentiation. Unlike their wild-type littermates, when treated with 7,12 dimethylbenzanthracene (DMBA) or
UVB, they develop skin tumors, including some characteristic of overexpression of the hedgehog (Hh) pathway.
Both the epidermis and utricles of the VDR-null animals overexpress elements of the Hh pathway (sonic hedgehog
(Shh) 2.02-fold, patched1 1.58-fold, smoothened 3.54-fold, glioma-associated oncogene homolog (Gli)1 1.17-fold,
and Gli2 1.66-fold). This overexpression occurs at an age (11 weeks) at which epidermal hyperproliferation is most
visible and is spatially controlled in the epidermis. DMBA- or UVB-induced tumors in the VDR-null mice also
overexpress elements of this pathway. Moreover, 1,25(OH)2D3 downregulates the expression of some members of
the Hh pathway in an epidermal explants culture system, suggesting a direct regulation by 1,25(OH)2D3. Our
results suggest that increased expression of Shh in the keratinocytes of the VDR-null animal activates the Hh
pathway, predisposing the skin to the development of both malignant and benign epidermal neoplasms.
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INTRODUCTION
Over 1 million skin cancers occur annually in the United
States, 80% of which are basal cell carcinomas (BCCs; 16%
squamous cell carcinomas (SCCs) and 4% melanomas),
making it by far the most common cancer (Greenlee
et al., 2001). 1,25 Dihydroxyvitamin D3 (1,25(OH)2D3) has
been evaluated for its potential anticancer activity (Eisman
et al., 1979), and the accepted basis for the promise of
1,25(OH)2D3 for the prevention and treatment of malig-
nancy includes its antiproliferative, prodifferentiating effects
on many cell types. Epidemiological evidence supports the
importance of adequate vitamin D nutrition for the preven-
tion of a number of cancers including those of the colon and
breast (Garland et al., 1985, 1990; Hanchette and Schwartz,
1992; Bostick et al., 1993; Kearney et al., 1996).
Recent studies indicate that vitamin D signaling has a
protective role in skin carcinogenesis. Zinser et al. (2002)
treated vitamin D receptor (VDR)-null mice (VDR knock-
out (VDRKO)) bearing medroxyprogesterone pellets with
two oral administrations of 7,12 dimethylbenzanthracene
(DMBA) at 5.5 and 7 weeks, a protocol designed to induce
breast cancers. No breast tumors were observed within 2
months; however, during this period, 85% of the VDRKO
mice developed skin tumors, whereas no tumors were found
in wild-type controls. The tumors were mostly sebaceous,
squamous, and follicular papillomas, but several BCCs were
also observed, whereas no SCCs were reported. These results
have recently been confirmed using topical administration
of DMBA/12-O-tetradecanoylphorbol-13-acetate, although
only papillomas were seen in the VDRKO mice, unlike
RXRaKO mice that developed both BCC and SCC (Indra
et al., 2007). The appearance of BCC in these studies is
surprising, as the typical malignancy induced in mouse skin
by UVR, ionizing radiation, or chemical carcinogens is SCC
rather than BCC (Daya-Grosjean and Sarasin, 2005). The
appearance of BCC is characteristic of tumors formed when
the hedgehog (Hh) signaling is activated (Regl et al., 2004a)
by mutations in the Hh signaling pathway, in particular
in patched1 (Ptch1) or overexpression of sonic hedgehog
(Shh), glioma-associated oncogene homolog (Gli)1, and Gli2
(Hahn et al., 1996; Johnson et al., 1996; Aszterbaum et al.,
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1998, 1999). The predisposition of VDRKO mice to skin
tumor formation has also been demonstrated using UVB
(Ellison et al., 2008).
Essentially all BCCs, whether arising sporadically or in
patients with basal-cell nevus syndrome (Gorlin syndrome),
have mutations in Ptch1, the membrane receptor for Shh,
or other alterations in Hh signaling (Hahn et al., 1996;
Aszterbaum et al., 1998, 1999). This phenotype is also
observed in the Ptch1þ / (Gorlin) mouse (Regl et al.,
2004a), which, unlike the wild-type mouse, produces BCC as
well as SCC after treatment with UVR or ionizing radiation
(Regl et al., 2004a). In the absence of Shh, Ptch1 inhibits
the function of another membrane protein, smoothened
(Smoh). Shh reverses this inhibition, freeing Smoh to enable
the activation of a family of transcription factors Gli1, Gli2,
and Gli3. Gli1 and Gli2 overexpression in keratinocytes can
increase the expression of each other, as well as Ptch1, the
antiapoptotic factor bcl2, cyclins D1 and D2, E2F1, cdc45
(all of which promote proliferation), while suppressing genes
associated with keratinocyte differentiation, such as K1, K10,
involucrin, loricrin, and the VDR (Grachtchouk et al., 2000;
Nilsson et al., 2000; Regl et al., 2002, 2004a, 2004b). Mice
overexpressing Gli1, Gli2, or Shh in their basal keratinocytes
(Oro et al., 1997; Grachtchouk et al., 2000; Nilsson et al.,
2000) or grafted with human keratinocytes overexpressing
Shh (Fan et al., 1997) develop BCC-like lesions. Furthermore,
BCCs show overexpression of Ptch1, Smoh, Gli1, and Gli2
(Tojo et al., 1999; Bonifas et al., 2001). Gli2 may be more
critical than Gli1 in mediating Shh activity in that Gli1-null
animals display no obvious phenotype unlike Gli2-null
animals. Gli2-null mice resemble Shh-null animals in pheno-
type, Gli2 deletion partially rescues Ptch1 null animals, and
Gli2 but not Gli1 is required for Shh signaling in hair follicle
development (reviewed in Eichberger et al. (2004)).
Most skin tumors induced by systemic DMBA in mice
lacking the VDR contain hair follicle elements and/or are
of basal-cell origin, tumors characteristic of overexpression
of the Hh pathway in keratinocytes. The VDR is found in the
outer root sheath and basal layer of the interfollicular
epidermis, a postulated source for BCC development (Bikle
et al., 2006). Lack of VDR causes a marked hyperproliferative
response in these cells of the hair follicle and epidermis,
with disruption of normal hair follicle cycling and decreased
epidermal differentiation (Xie et al., 2002; Bikle et al., 2006).
We found that the epidermis and epidermal portion (utricles)
of the hair follicles of VDRKO animals overexpress elements
of the Hh signaling pathway (Shh, Ptch1, Smoh, Gli1, and
Gli2), suggesting that one of the causes of the increased
susceptibility of the epidermis to malignant transformation is
due to a loss of 1,25(OH)2D3 and/or VDR regulation of Hh
signaling. When we examined tumors in VDRKO mice
treated with DMBA or UVB, we found the overexpression of
the same elements of the Hh signaling pathway predomi-
nantly in the tumors compared with adjacent tissue. Using
an epidermal explant culture, we found that 1,25(OH)2D3
represses the expression of at least some members of the
Hh signaling pathway, suggesting a direct regulation by
the VDR.
RESULTS
Acute UVB exposure increased epidermal thickness and
proliferation in VDRKO mice
To address the short-term sensitivity of skin to UVB exposure,
we irradiated wild-type and VDRKO mice with a single dose
of UVB (400mJ cm2). Wild-type mice displayed increased
epidermal thickening 1 h and 24 h after exposure to UVB
with no further increase by 48 h (Figure 1a). This was accom-
panied with increased proliferating cell nuclear antigen
staining, a marker of cellular proliferation, in the epidermis
at 1 h and 24 h, with no further increase by 48 h (Figure 1b).
VDRKO mice displayed a more pronounced epidermal
hyperplasia at all time points compared with wild-type mice
(Figure 1a), showing an increased and more durable hyper-
plasia. Consistent with the increased thickening, VDRKO
mice had increased numbers of proliferating cell nuclear
antigen-positive cells compared with wild-type mice at 1 h
and 24 h, and these continued to increase at 48 h (Figure 1b).
Overexpression of the Hh pathway members in VDRKO mice
To address the long-term sensitivity of VDRKO mice
epidermis to tumor formation, we assessed the protein levels
of multiple members of the Hh pathway in VDRKO mice
and their wild-type littermates by immunohistochemistry and
western blotting. We examined 11-week-old mice, the age
matching the appearance of the skin papillomas in VDRKO
mice treated with DMBA (Zinser et al., 2002). In wild-type
mice, Shh, Ptch1, and Smoh were expressed in both hair
follicles and interfollicular epidermis, whereas Gli1 was
expressed mostly in hair follicles, and Gli2 expression was
not detectable. Expression of all these proteins increased
in VDRKO mice compared with their wild-type littermates
(Figure 2a), and their spatial distribution was also affected by
the lack of VDR. Shh expression increased in the epidermis of
the VDRKO mice, but was markedly reduced in the utricles,
the remaining portion of the hair follicle structures. Ptch1 was
expressed throughout the epidermis and the hair follicle of
the wild-type mice, but primarily in the utricles and dermal
cysts of the VDRKO mice. Smoh and Gli1 expression, found
primarily in the outer root sheath of the hair follicles of
wild-type mice, increased in both hair follicles and inter-
follicular epidermis of the VDRKO mice. Gli2 expression,
not detectable in wild-type mice, was strongly expressed in
utricles and dermal cysts of VDRKO mice. We confirmed
quantitatively the increased expression of these proteins using
western blotting. When compared with the housekeeping
gene b-actin, we found an increased expression of Shh (2.02-
fold), Ptch1 (1.58-fold), Smoh (3.54-fold), Gli1 (1.17-fold),
and Gli2 (1.66-fold) in skin from VDRKO mice compared
with their wild-type littermates (Figure 2b).
Different types of skin tumors are induced by UVB in VDRKO
mice
VDRKO mice exposed to 40 weeks of UVB irradiation devel-
oped an average of 2.7 skin tumors 41mm in diameter per
mouse, with at least one tumor per mouse. These tumors
included papillomas (78%), BCCs (11%), SCCs (7.5%), and
keratoacanthomas (3.5%). Representative sections of these
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tumors are presented in Figure 3a. Furthermore, after 40
weeks of UVB no tumors were apparent in wild-type and
CYP27B1KO mice (Figure 3b and data not shown). No
tumors developed in the VDRKO mice that were not exposed
to DMBA or UVB (Figure 3b and data not shown).
DMBA- and UVB-induced skin tumors in VDRKO mice express
members of the Hh pathway
We then examined the expression of the Hh signaling path-
way members by immunohistochemistry in tumors formed
in VDRKO mice following DMBA and UVB treatment. In all
these tumors, we were able to find expression of Shh, Smoh,
Ptch1, Gli1, and Gli2 (Figure 4a and data not shown). More-
over, the expression of these markers was mostly localized to
the tumor with little or no expression in adjacent tissues
(Figure 4a and data not shown). We confirmed the expression
of these proteins specifically in the DMBA-generated skin
tumors using western analysis of protein extracts from these
tumors (Figure 4b). When compared with the housekeeping
gene b-actin, we found an increased expression of Shh
(3.08-fold), Ptch1 (1.53-fold), Smoh (3.65-fold), Gli1 (1.75-
fold), and Gli2 (1.56-fold) in the tumors compared with
tumor-free tissue (Figure 4b).
1,25(OH)2D3 repression of the Hh pathway in the epidermis
To determine whether 1,25(OH)2D3 directly regulates the
expression of components of the Hh pathway, we measured
their expression levels in epidermal explants from wild-type
mice, following treatment with 1,25(OH)2D3 concentrations
ranging from 1010 M to 107 M. Shh was robustly expressed
in neonatal epidermal explants but not in proliferating
keratinocytes in culture (data not shown). After treat-
ment with 1,25(OH)2D3, the epidermal explants displayed
increased expression of 25-hydroxyvitamin D3-24-hydroxy-
lase and decreased expression of Shh, Gli1, Gli2, and Ptch1
in a dose-dependent manner (Figure 5a). To verify that
1,25(OH)2D3 regulation of the expression of those genes was
dependent on the VDR, we measured their expression levels
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Figure 1. Increased hyperplasia and hyperproliferation in UVB-exposed epidermis from VDRKO mice. Wild-type mice exposed to 1 dose of UVB
(477mJ cm2) show epidermal hyperplasia (a, hematoxylin and eosin staining) and increased proliferation (b, proliferating cell nuclear antigen staining),
1 h and 24 h after treatment with no further increase at 48 h. VDRKO mice exposed to the same dose of UVB show significantly more pronounced epidermal
hyperplasia (a) at 1 h and 24 h that continued to increase at 48 h. VDRKO epidermis also shows increased proliferation (b) comparable to that of wild-type
mice at 1 h and 24h that continued to increase at 48 h. *Po0.05. VDRKO, vitamin D receptor knockout. Bar¼ 50mm.
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in epidermal explants from VDRKO mice compared with
wild-type mice. Treatment with 108 M of 1,25(OH)2D3
decreased the expression of Shh (3.5-fold), Gli1 (2.4-fold),
Gli2 (2.3-fold), and Ptch1 (2-fold) in wild-type epidermis.
Smoh expression was not affected. In contrast, 1,25(OH)2D3
inhibition of their expression was suppressed in VDRKO
samples (Figure 5b). Lack of VDR in VDRKO samples
was verified by the lack of VDR expression and the inabi-
lity of 1,25(OH)2D3 to induce 25-hydroxyvitamin D3-24-
hydroxylase expression, compared with wild-type samples
(500-fold increase, Figure 5b). Immunohistochemistry con-
firmed that Shh is expressed in the most differentiated layer of
the epidermis but not in the basal layer of these explants
(Figure 5c).
DISCUSSION
Following recent studies showing the sensitivity of VDRKO
mice to skin tumor formation upon exposure to carcinogen
(Zinser et al., 2002) or to UVB (Ellison et al., 2008), we
investigated potential mechanisms by which VDR could
function as a tumor suppressor. VDRKO mice show increased
sensitivity to acute UVB irradiation with respect to epidermal
thickening and hyperproliferation. Hyperproliferation being
a key element in tumor formation, our data indicate a predis-
position of VDRKO epidermis to develop skin tumors,
although no tumors were found in the VDRKO mice not
exposed to UVB. Hyperproliferation was also observed in
wild-type mice, to a lesser extent, but no tumors arise in those
mice following 40 weeks of UVB exposure. In a comparable
study (Ellison et al., 2008), wild-type mice developed tumors
after 45 weeks of exposure to UVB, with an incidence of 85%
lower than that in VDRKO. As a potential mechanism for this
hyperproliferative response, we found that the epidermal
portion (utricles) of the hair follicles and the dermal cysts of
VDRKO animals overexpress elements of the Hh signaling
pathway, suggesting that one of the causes of the increased
susceptibility of the VDRKO epidermis to malignant trans-
formation is due to the loss of 1,25(OH)2D3 and/or VDR
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Figure 2. Increased protein levels of Hh signaling pathway members in VDRKO mice. (a) Shh, Ptch1, Smoh, Gli1, and Gli2 proteins as shown by
the brown signal were detected in the epidermis and hair follicles from VDRKO mice and their wild-type littermates at 11 weeks after birth by
immunocytochemistry. Slides were counterstained with hematoxylin (blue stain). Bar¼50 mm. (b) Shh, Ptch1, Smoh, Gli1, and Gli2 protein levels
were quantified by western blot in skin from VDRKO mice and their wild-type littermates and compared with b-actin as a control. The numerical value
represents the average ratio of VDRKO band intensity versus wild-type band intensity after subtraction of background level from three independent
experiments. *Po0.05. Gli1, glioma-associated oncogene homolog; Hh, hedgehog; Ptch1, patched1; Shh, sonic hedgehog; Smoh, smoothened; VDRKO,
vitamin D receptor knockout; WT, wild type.
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regulation of Hh signaling. This potential mechanism is
further supported by the expression of elements of the Hh
signaling pathway in the tumors arising in VDRKO mice
treated with DMBA or UVB and the observation that
1,25(OH)2D3 suppresses the expression of the Hh signaling
pathway in a VDR-dependent manner.
Lack of VDR increases the protein expression of the Hh
pathway members Shh, Ptch1, Smoh, Gli1, and Gli2 in
VDRKO mice. Our data show that these proteins are
expressed in a spatially controlled way in the wild-type
animals and in the VDRKO even if the levels and areas of
expression change. As one of the main skin defects of the
VDRKO mice is a blockage of their hair follicle cycling by the
end of the first cycle and a progressive hair loss (Li et al.,
1997; Bikle et al., 2006), one might consider that the hair
follicle is the main target and regulator of the Hh signaling
pathway. When this structure is missing or, as in VDRKO
mice, altered to become utricles and dermal cysts, the Hh
signaling pathway is overexpressed in the epidermal and
interfollicular epidermal parts of the skin, thus potentially
predisposing it to develop tumors. Paradoxically, loss of
Hh signaling in the cycling portion of the hair follicle may
contribute to its failure to cycle, as we recently show that
VDRKO hair follicles have a decreased expression of Hh
signaling and that treatment with an Hh signaling agonist
restores partially hair follicle cycling (Teichert et al., 2010).
Moreover, we found that the Hh signaling pathway expres-
sion is spatially controlled in the epidermis. Shh, for example,
is expressed in the most differentiated parts of the epidermis,
whereas other members of the pathway have a different distri-
bution, implying a paracrine action for Shh in the epidermis/
hair follicle. The separation of the different components of
the Hh pathway may explain why keratinocytes in culture
express little or no Shh if various feedback/feedforward loops
between the different layers of the skin are disrupted in
monocultures.
The tumors observed in VDRKO mice treated by DMBA
or UVB expressed all the Hh signaling pathway members
analyzed in this study, although as in the normal skin expres-
sion of these different pathway members varies in different
cells of the tumor, suggesting that the role of the Hh pathway
signaling components to the formation of these tumors results
from the contribution of different cell types.
Thus, we postulate that increased expression of Shh in
the keratinocytes of the VDRKO mouse activates the Hh
signaling pathway, predisposing the skin to the development
of tumors in part by stimulating proliferation. Our data using
epidermal preparations show that 1,25(OH)2D3 represses the
expression of this pathway in a VDR-dependent manner,
indicating a direct regulation of the Hh pathway by
vitamin D. Others have observed that vitamin D may regulate
this pathway not only via the genomic actions of 1,25(OH)2D3
functioning through VDR but also by direct inhibition by
vitamin D independent of its receptor. The latter possibility
stems from recent observations that vitamin D itself, as well as
its precursor 7-dehydrocholesterol, can bind to and inhibit the
actions of Smoh, a critical step in Hh signaling (Bijlsma et al.,
2006). Thus, both genomic and non-genomic actions of
vitamin D may serve to block tumor formation in the skin.
Our data show that over expression of Hh signaling
members in VDRKO mice arises when the utricles are well
established and the epidermis is clearly hyperproliferative.
This suggests that Hh signaling and the loss of the proximal
portion of the hair follicle defect might be associated. One
explanation might be that the subtle balance of expression of
this pathway between the dermal and epidermal parts of the
Papilloma SCC Keratoacanthoma
8-Month-old VDRKO, no UVB 8-Month-old wild type, UVB
BCC
Figure 3. Skin structures induced by UVB in VDRKO mice. (a) Representative structures from mice exposed to 40 weeks of UVB irradiation were collected
and classified into papillomas, SCCs, keratoacanthomas, and BCCs. (b) Representative structure of 8-month-old VDRKO skin without UVB exposure and
wild-type mice after 40 weeks of UVB exposure. BCC, basal cell carcinoma; SCC, squamous cell carcinoma; VDRKO, vitamin D receptor knockout.
Bar¼50 mm.
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skin is impaired by the lack of VDR. Specifically, in VDRKO
mice, the dermal papilla, which has an important role in hair
follicle development and cycling, is dissociated from the hair
follicle (Bikle et al., 2006). Thus, the overexpression of Hh
signaling in the epidermis of the VDRKO mice may increase
sensitivity toward carcinogenesis, whereas at the same time
the loss of Hh signaling in the cycling portion of the hair
follicle contributes to its failure to cycle. This duality of the
role of Hh signaling in the skin between hair follicle and
epidermis and its differential regulation by 1,25(OH)2D3/
VDR is reminiscent of an analogous duality with respect to
wnt/b-catenin signaling and its regulation by 1,25(OH)2D3/
VDR (Palmer et al., 2008). Thus, although we have focused
on the Hh signaling pathway in this study, these effects of
vitamin D signaling on tumor predisposition in the epidermis
will no doubt involve a number of pathways involving
both the hair follicle and the epidermis that are yet to be
fully explored.
MATERIALS AND METHODS
Animals
All animal experimentation described in the manuscript has been
approved by the San Francisco VA Medical Center Animal Review
Committee.
Mice heterozygous for the VDR-null mutation, Vdrtm1Ska, bred
into the C57BL/6 background, were provided by Dr Shigeaki Kato
(Molecular and Cellular Biosciences, University of Tokyo, Japan).
These mice were bred to provide wild-type and homozygous mutant
VDRKO littermates. Genotyping was performed by PCR with
different primers designed to amplify the mutant VDR DNA and
the wild-type VDR DNA (Table 1a). VDRKO DMBA-treated mouse
samples were provided from experiments described previously
(Zinser et al., 2002).
For UVB exposure, dorsal skin was shaved 24 h before UVB
exposure. Mice (5 weeks old at the start of the study) were irradiated
three times per week, with 2–3 days between treatments, and
reshaved as needed. The dorsal skin was exposed to UV irradiation
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Figure 4. Expression of members of the Hh signaling pathway in the tumors from VDRKO mice. (a) Shh, Ptch1, Smoh, Gli1, and Gli2 proteins as shown by
the brown signal were detected by immunohistochemistry in a papilloma from a VDRKO mouse treated with DMBA and in a BCC from a VDRKO mouse
treated with UVB. Slides were counterstained with hematoxylin (blue stain). Bar¼50mm. (b) Shh, Ptch1, Smoh, Gli1, and Gli2 protein levels were measured
by western blot in skin tumors and tumor-free tissue from DMBA-treated VDRKO mice. The numerical value represents the mean ratio of the tumor band
intensity versus tumor-free tissue band intensity after subtraction of background level from three independent experiments. *Po0.05. BCC, basal cell carcinoma;
DMBA, 7,12 dimethylbenzanthracene; Gli1, glioma-associated oncogene homolog; Hh, hedgehog; Ptch1, patched1; Shh, sonic hedgehog; Smoh, smoothened;
VDRKO, vitamin D receptor knockout.
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from a band of six FS-40 fluorescent lamps (Daavlin, Bryan, OH);
UVB and UVC wavelengths were filtered out from this UV light
using Kodacel cellulose film (Daavlin). The dose of UVB varied to
maximize UV exposure with minimal ulceration of the skin, using
the following protocol: 120mJ cm2 for 2 weeks, the dose was then
increased to 25% per week for 5 weeks, up to 400mJ cm2 for 9
weeks, followed by 200mJ cm2 until week 40 (Ellison et al., 2008).
Skin tumors were characterized with the help of the dermatopathol-
ogy department of the San Francisco VA Medical Center.
Immunohistochemistry
Affinity-purified antibodies (Santa Cruz Biotechnology, Santa Cruz,
CA) found to recognize mouse proteins following heat-induced antigen
retrieval treatment (in 10mM citrate buffer, pH 6.0, at 95 1C, for
30min) were used. The primary antibodies were used at a concen-
tration of 4mgml1 in 10mM Tris buffer, pH 7.6, containing 4%
BSA, 1% teleostean skin gelatin, 0.1% Tween 20, and 500mM NaCl.
The binding of the primary antibody to the sections was detected
by affinity-purified, biotinylated goat anti-rabbit IgG, followed by
ABC-peroxidase reagent, both purchased from Vector (Burlingame,
CA). Peroxidase activity was detected with diaminobenzidine substrate
(QualTek Laboratories, Santa Barbara, CA), followed by counter-
staining with methyl green or hematoxylin. Omitting the first antibody
resulted in no signal, indicating the specificity of the immunodetection.
Protein extraction and western blot
Proteins were extracted from the back skin of mice or from the DMBA-
treated tumors after homogenization with a polytron in RIPA buffer
(150mM NaCl, 1% NP-40, 0.5% deoxycholic acid, 0.1% SDS, and
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Figure 5. 1,25(OH)2D3, through VDR action, represses the Hh pathway expression in the epidermis. (a) 1,25(OH)2D3 treatment of epidermal preparations
from wild-type mice in culture for 24 h induced Cyp24 expression and repressed Shh, Gli1, Gli2, and Ptch1 expression in a dose-dependent manner.
(b) Epidermal preparations from wild-type and VDRKO mice in culture were treated with 1,25(OH)2D3 10
8
M or EtOH for 24 h. The absence of VDR
expression was verified in VDRKO mice and their epidermis failed to respond to 1,25(OH)2D3 induction of Cyp24 expression unlike that in wild-type
mice. 1,25(OH)2D3 treatment repressed Shh, Gli1, Gli2, and Ptch1 expression only in wild-type preparations. *Po0.05 (c). Shh protein expression was
localized in the upper layers of the epidermis by immunohistochemistry on a full skin section. Bar¼ 50mm. 1,25(OH)2D3, 1,25 dihydroxyvitamin D3;
Cyp24, 25-hydroxyvitamin D3-24-hydroxylase; Gli1, glioma-associated oncogene homolog; Hh, hedgehog; Ptch1, patched1; Shh, sonic hedgehog; Smoh,
smoothened; VDRKO, vitamin D receptor knockout.
Table 1. List of primers used for genotyping
Gene Forward primer (50–30) Reverse primer (50–30)
VDRKO CGGTGCCCTGAATGAACTGC GGGAAGCCAAGAGGGGAGTC
VDR GCCACGGGCTTCCACTTCAA GGGAAGCCAAGAGGGGAGTC
Abbreviations: VDR, vitamin D receptor; VDRKO, VDR knockout.
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50mM Tris). Protein concentrations were determined by the BCA Protein
Assay Kit (Pierce, Rockford, IL). Equal amounts of protein samples were
electrophoresed through 4–15% gradient polyacrylamide gels and
electroblotted onto polyvinylidene fluoride membranes (Immobilon-P,
0.45mm; Millipore, Bedford, MA). After incubation in blocking buffer
(PBS, 5% non-fat milk, and 0.5% Tween 20), the blot was incubated
overnight at 4 1C with appropriate primary antibodies: polyclonal
antibody against mouse Gli1 (Abcam, Cambridge, MA) at a dilution of
1:1,000, Gli2, patched, Shh, or Smoh (Santa Cruz Biotechnology) at a
dilution of 1:200. After washing three times with the blocking buffer, the
membranes were incubated for 1h with the appropriate anti-IgG
secondary antibody conjugated to horseradish peroxidase (Amersham
Biosciences, Piscataway, NJ) in the blocking buffer. After a second series
of washes, bound antibody complexes were visualized using the
SuperSignal ULTRA chemiluminescent kit (Pierce) and subsequent
exposure to X-ray film. X-ray films were then scanned and the intensity
of each band was quantified using Kodak 1D 3.6.4 (Kodak, Rochester,
NY). The data presented are representative of three independent
experiments.
Skin separation and cell culture
Skin separation was performed as described by Lichti et al. (2008).
Briefly, back skin from neonatal mice was collected and separated
overnight in Hank’s balanced salt solution with 5Uml1 dispase.
Epidermal sheets (epidermal explants) were then peeled from the
dermal fraction and maintained in culture in 154CF medium
(Cascade Biologics, Portland, OR) with 1.2mM CaCl2 and 10%
chelexed fetal bovine serum. Epidermal explants were treated for
24 h with 1,25(OH)2D3 (10
10–to 107 M) or vehicle (100% ethanol).
Quantitative real-time PCR
Total RNA from back skin of mice, separated epidermis, and
dermis or cell culture was extracted using RNA-STAT 60 (Tel-Test,
Friendswood, TX). Concentration and purity were determined by
measuring the absorbance at optical density 260/280 nm. RNA (1mg)
was reverse transcribed using random hexamers with the TaqMan
reverse transcription kit (Applied Biosystems, Foster City, CA). The
amount of complementary DNA was then quantified by quantitative
real-time PCR, performed on a PE Biosystems model 7900 HT
sequence detector. The PCR amplification was done using TaqMan
Universal PCR Master Mix (Applied Biosystems) and TaqMan Gene
Expression Assays (Applied Biosystems, Carlsbad, CA) using their
proprietary primer/probe sets or SYBRGreen Universal PCR Master
Mix (Applied Biosystems) and primers from PrimerBank (Wang and
Seed, 2003). Mitochondrial ribosomal protein L19 (Mrpl19) was
used as the control gene to which the results were normalized.
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